NCT05959213View on ClinicalTrials.gov

Preoperative CA 19.9 Level Predicts Lymph Node Metastasis in Resectable Adenocarcinoma of the Head of the Pancreas.

CompletedOBSERVATIONAL
Enrollment

2,034

Participants

Timeline

Start Date

January 1, 2000

Primary Completion Date

June 30, 2022

Study Completion Date

March 1, 2023

Conditions
Pancreas Cancer
All Listed Sponsors
lead

Fondazione Policlinico Universitario Campus Bio-Medico

OTHER